Human skin dendritic cell fate is differentially regulated by the monocyte identity factor Kruppel-like factor 4 during steady state and inflammation

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 6, 2017, Pages 1873-1884.e10

  Jurkin, Jennifer ^b,f,g   Krump, Corinna ^a   Köffel, René ^b   Fieber, Christina ^b   Schuster, Christopher ^c   Brunner, Patrick M ^c   Borek, Izabela ^a   Eisenwort, Gregor ^b   Lim, Clarice ^a,b   Mages, Jörg ^e   Lang, Roland ^e   Bauer, Wolfgang ^c   Mechtcheriakova, Diana ^d   Meshcheryakova, Anastasia ^d   Elbe Bürger, Adelheid ^c   Stingl, Georg ^c   Strobl, Herbert ^a,b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Universitatsklinik fur Dermatologie   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

^g UNIVERSITY OF BERN   (Switzerland)

Author keywords

Kruppel like factor 4; lineage decision; monocyte differentiation; Notch; Runt related transcription factor 3; TGF 1 signaling

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; KRUPPEL LIKE FACTOR 4; LANGERIN; NOTCH RECEPTOR; T6 ANTIGEN; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA1; KRUPPEL LIKE FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL LINEAGE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS CELL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; IN VITRO STUDY; INFLAMMATORY DISEASE; MONOCYTE; MONOCYTE MACROPHAGE PRECURSOR CELL; NORMAL HUMAN; NOTCH SIGNALING; PRIORITY JOURNAL; SKIN; STEADY STATE; UMBILICAL CORD BLOOD CELL; WESTERN BLOTTING; ADULT; CELL CULTURE; CYTOLOGY; FETUS BLOOD; INFLAMMATION; MAMMALIAN EMBRYO; METABOLISM; PHYSIOLOGY;

ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; EMBRYO, MAMMALIAN; FETAL BLOOD; HUMANS; INFLAMMATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MONOCYTES; SKIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85006288771     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.09.018     Document Type: Article

References (68)

1. Kaplan, D.H., In vivo function of Langerhans cells and dermal DC. Trends Immunol 31 (2010), 446–451.
2. Merad, M., Ginhoux, F., Collin, M., Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8 (2008), 935–947.
3. Eisenwort, G., Jurkin, J., Yasmin, N., Bauer, T., Gesslbauer, B., Strobl, H., Identification of TROP2 (TACSTD2), an EpCAM-like molecule, as a specific marker for TGF-β1-dependent human epidermal Langerhans cells. J Invest Dermatol 131 (2011), 2049–2057.
4. Gaiser, M.R., Lämmermann, T., Feng, X., Igyarto, B.Z., Kaplan, D.H., Tessarollo, L., et al. Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo. Proc Natl Acad Sci U S A 109 (2012), E889–E897.
5. Zimmerli, S.C., Hauser, C., Langerhans cells and lymph node dendritic cells express the tight junction component claudin-1. J Invest Dermatol 127 (2007), 2381–2390.
6. Seneschal, J., Clark, R.A., Gehad, A., Baecher-Allan, C.M., Kupper, T.S., Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36 (2012), 873–884.
7. McGovern, N., Schlitzer, A., Gunawan, M., Jardine, L., Shin, A., Poyner, E., et al. Human dermal CD14+ cells are a transient population of monocyte-derived macrophages. Immunity 41 (2014), 465–477.
8. Strobl, H., Bello-Fernandez, C., Riedl, E., Pickl, W.F., Majdic, O., Lyman, S.D., et al. flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 90 (1997), 1425–1434.
9. Ginhoux, F., Tacke, F., Angeli, V., Bogunovic, M., Loubeau, M., Dai, X.-M., et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 7 (2006), 265–273.
10. Seré, K., Baek, J.H., Ober-Blöbaum, J., Müller-Newen, G., Tacke, F., Yokota, Y., et al. Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity 37 (2012), 905–916.
11. Geissmann, F., Prost, C., Monnet, J.P., Dy, M., Brousse, N., Hermine, O., Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 187 (1998), 961–966.
12. Hoshino, N., Katayama, N., Shibasaki, T., Ohishi, K., Nishioka, J., Masuya, M., et al. A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes. J Leukoc Biol 78 (2005), 921–929.
13. Pickl, W.F., Majdic, O., Kohl, P., Stöckl, J., Riedl, E., Scheinecker, C., et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol 157 (1996), 3850–3859.
14. Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., et al. Dendritic cell subsets in health and disease. Immunol Rev 219 (2007), 118–142.
15. Klechevsky, E., Liu, M., Morita, R., Thompson-snipes, L., Palucka, A.K., Banchereau, J., et al. Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines. Hum Immunol 70 (2009), 281–288.
16. Göbel, F., Taschner, S., Jurkin, J., Konradi, S., Vaculik, C., Richter, S., et al. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation. Blood 114 (2009), 3813–3821.
17. Yasmin, N., Konradi, S., Eisenwort, G., Schichl, Y.M., Seyerl, M., Bauer, T., et al. β-Catenin promotes the differentiation of epidermal Langerhans dendritic cells. J Invest Dermatol 133 (2013), 1250–1259.
18. Fainaru, O., Woolf, E., Lotem, J., Yarmus, M., Brenner, O., Goldenberg, D., et al. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 23 (2004), 969–979.
19. Heinz, L.X., Platzer, B., Reisner, P.M., Jörgl, A., Taschner, S., Göbel, F., et al. Differential involvement of PU.1 and Id2 downstream of TGF-β1 during Langerhans-cell commitment. Blood 107 (2006), 1445–1453.
20. Chopin, M., Seillet, C., Chevrier, S., Wu, L., Wang, H., Morse, H.C. 3rd, et al. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. J Exp Med 210 (2013), 2967–2980.
21. Ratzinger, G., Baggers, J., de Cos, M., Yuan, J., Dao, T., Reagan, J.L., et al. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J Immunol 173 (2004), 2780–2791.
22. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Durand, I., Cella, M., et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 90 (1997), 1458–1470.
23. Gatti, E., Velleca, M., Biedermann, B.C., Ma, W., Unternaehrer, J., Ebersold, M.W., et al. Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors. J Immunol 164 (2000), 3600–3607.
24. Varnum-Finney, B., Wu, L., Yu, M., Brashem-Stein, C., Staats, S., Flowers, D., et al. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J Cell Sci 113 (2000), 4313–4318.
25. Platzer, B., Jörgl, A., Taschner, S., Höcher, B., Strobl, H., RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 104 (2004), 3655–3663.
26. Jörgl, A., Platzer, B., Taschner, S., Heinz, L.X., Hocher, B., Reisner, P.M., et al. Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB. Blood 109 (2007), 185–193.
27. Lansdorp, P.M., Sutherland, H.J., Eaves, C.J., Selective expression of CD45 isoforms on functional subpopulations of CD34 + hemopoietic cells from human bone marrow. Cytometry 172 (1990), 363–366.
28. Canque, B., Camus, S., Dalloul, A., Kahn, E., Yagello, M., Dezutter-Dambuyant, C., et al. Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells. Blood 96 (2000), 3748–3756.
29. Manz, M.G., Miyamoto, T., Akashi, K., Weissman, I.L., Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A 99 (2002), 11872–11877.
30. Haddad, R., Guardiola, P., Izac, B., Thibault, C., Radich, J., Delezoide, A., et al. Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood 104 (2004), 3918–3926.
31. Feinberg, M.W., Wara, A.K., Cao, Z., Lebedeva, M.A., Rosenbauer, F., Iwasaki, H., et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J 26 (2007), 4138–4148.
32. Alder, J.K., Georgantas, R.W. 3rd, Hildreth, R.L., Kaplan, I.M., Morisot, S., Yu, X., et al. Kruppel-like factor 4 is essential for in ammatory monocyte differentiation in vivo. J Immunol 180 (2008), 5645–5652.
33. Pearson, R., Fleetwood, J., Eaton, S., Crossley, M., Bao, S., Kruppel-like transcription factors: a functional family. Int J Biochem Cell Biol 40 (2008), 1996–2001.
34. Spittau, B., Krieglstein, K., Klf10 and Klf11 as mediators of TGF-beta superfamily signaling. Cell Tissue Res 347 (2012), 65–72.
35. Feinberg, M.W., Cao, Z., Wara, A.K., Lebedeva, M.A., SenBanerjee, S., Jain, M.K., Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J Biol Chem 280 (2005), 38247–38258.
36. Schuster, C., Vaculik, C., Fiala, C., Meindl, S., Brandt, O., Imhof, M., et al. HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells. J Exp Med 206 (2009), 169–181.
37. Jin, S., Mutvei, A.P., Chivukula, I.V., Andersson, E.R., Ramsköld, D., Sandberg, R., et al. Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ. Oncogene 32 (2013), 4892–4902.
38. Hirata, N., Yamada, S., Shoda, T., Kurihara, M., Sekino, Y., Kanda, Y., Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation. Nat Commun, 5, 2014, 4806.
39. Hutter, C., Kauer, M., Simonitsch-Klupp, I., Jug, G., Schwentner, R., Leitner, J., et al. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood 120 (2012), 5199–5208.
40. Bray, S., Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7 (2006), 678–689.
41. Riedl, E., Stöckl, J., Majdic, O., Scheinecker, C., Rappersberger, K., Knapp, W., et al. Functional involvement of E-cadherin in TGF-beta 1-induced cell cluster formation of in vitro developing human Langerhans-type dendritic cells. J Immunol 165 (2000), 1381–1386.
42. Riedl, E., Stöckl, J., Majdic, O., Scheinecker, C., Knapp, W., Strobl, H., Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood 96 (2000), 4276–4284.
43. Yusuf, I., Kharas, M.G., Chen, J., Peralta, R.Q., Maruniak, A., Sareen, P., et al. KLF4 is a FOXO target gene that suppresses B cell proliferation. Int Immunol 20 (2008), 671–681.
44. Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., Thompson-Snipes, L., et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29 (2008), 497–510.
45. Wollenberg, A., Mommaas, M., Oppel, T., Schottdorf, E.M., Gunther, S., Moderer, M., Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Invest Dermatol 118 (2002), 327–334.
46. Jaksits, S., Kriehuber, E., Charbonnier, A.S., Rappersberger, K., Stingl, G., Maurer, D., CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J Immunol 163 (1999), 4869–4877.
47. Mildner, A., Jung, S., Development and function of dendritic cell subsets. Immunity 40 (2014), 642–656.
48. Tussiwand, R., Everts, B., Grajales-Reyes, G.E., Kretzer, N.M., Iwata, A., Bagaitkar, J., et al. Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. Immunity 42 (2015), 916–928.
49. Larregina, A.T., Morelli, A.E., Spencer, L.A., Logar, A.J., Watkins, S.C., Thomson, A.W., et al. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol 2 (2001), 1151–1158.
50. Xu, Y., Xue, S., Zhou, J., Voorhees, J.J., Fisher, G.J., Notch and TGF-β pathways cooperatively regulate receptor protein tyrosine phosphatase-κ (PTPRK) gene expression in human primary keratinocytes. Mol Biol Cell 26 (2015), 1199–1206.
51. Milne, P., Bigley, V., Gunawan, M., Haniffa, M., Collin, M., CD1c+ blood dendritic cells have Langerhans cell potential. Blood 125 (2015), 470–473.
52. Zheng, H., Pritchard, D.M., Yang, X., Bennett, E., Liu, G., Liu, C., et al. KLF4 gene expression is inhibited by the notch signaling pathway that controls goblet cell differentiation in mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 296 (2009), G490–G498.
53. Hu, D., Wan, Y., Regulation of Kruppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-beta signaling. J Biol Chem 286 (2011), 6890–6901.
54. Senechal, B., Elain, G., Jeziorski, E., Grondin, V., De Serre, N.P.M., Jaubert, F., et al. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med 4 (2007), 1374–1384.
55. Stary, G., Klein, I., Bauer, W., Koszik, F., Reininger, B., Kohlhofer, S., et al. Glucocorticosteroids modify Langerhans cells to produce TGF-β and expand regulatory T cells. J Immunol 186 (2011), 103–112.
56. Ohishi, K., Varnum-Finney, B., Serda, R.E., Anasetti, C., Bernstein, I.D., The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood 98 (2001), 1402–1407.
57. Hacker, C., Kirsch, R.D., Ju, X.S., Hieronymus, T., Gust, T.C., Kuhl, C., et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 4 (2003), 380–386.
58. Varnum-Finney, B., Wu, L., Yu, M., Brashem-Stein, C., Staats, S., Flowers, D., et al. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J Cell Sci 113 (2000), 4313–4318.
59. Strobl, H., Bello-Fernandez, C., Riedl, E., Pickl, W.F., Majdic, O., Lyman, S.D., et al. flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 90 (1997), 1425–1434.
60. Stary, G., Klein, I., Brüggen, M.-C., Kohlhofer, S., Brunner, P.M., Spazierer, D., et al. Host defense mechanisms in secondary syphilitic lesions. Am J Pathol 177 (2010), 2421–2432.
61. Gold, D., Coombes, K., Medhane, D., Ramaswamy, A., Ju, Z., Strong, L., et al. A comparative analysis of data generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays. BMC Genomics, 5, 2004, 2.
62. Hutter, C., Kauer, M., Simonitsch-Klupp, I., Jug, G., Schwentner, R., Leitner, J., et al. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood 120 (2012), 5199–5208.
63. Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B., Speed, T.P., Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res, 31, 2003, e15.
64. Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol, 5, 2004, R80.
65. Jörgl, A., Platzer, B., Taschner, S., Heinz, L.X., Hocher, B., Reisner, P.M., et al. Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB. Blood 109 (2007), 185–193.
66. Platzer, B., Jörgl, A., Taschner, S., Höcher, B., Strobl, H., RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 104 (2004), 3655–3663.
67. Feinberg, M.W., Wara, A.K., Cao, Z., Lebedeva, M.A., Rosenbauer, F., Iwasaki, H., et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J 26 (2007), 4138–4148.
68. Schuster, C., Vaculik, C., Fiala, C., Meindl, S., Brandt, O., Imhof, M., et al. HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells. J Exp Med 206 (2009), 169–181.